window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 13, 2026

  • News
  • About Us
Contact Us

contract packaging

  • CDMOs & Manufacturing,Packaging,Supply Chain & Logistics

    Eight maids a-milking: Tjoapack’s hopes and predictions for 2026

    As part of our festive 12 days of Christmas predictions, Tjoapack [...]

    December 19, 2025
  • CDMOs & Manufacturing,Packaging,Supply Chain & Logistics

    Three French Hens and a year of agility: Tjoapack reflects on 2025

      On the third day of our 12 Days of [...]

    December 18, 2025
  • Facilities and infrastructure,Logistics and distribution,Market Access & Commercialization,Packaging

    Tjoapack expands US site to bolster packaging capacity and cold chain capabilities

    Tjoapack is expanding its US operations with a major build [...]

    December 10, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Drug Delivery & Formulation,Supply Chain & Logistics

    Tjoapack expands biologics packaging and cold chain capacity in USA and Europe

    Tjoapack, a leading contract packaging organization serving the pharmaceutical industry, [...]

    June 9, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  •
    Trenchant BioSystems confirms AutoCell platform can cut CGT manufacturing to 2.5 days
    Categories: Biomanufacturing, Cell & Gene Therapy, Clinical Development, Drug Development, Technology and platforms
  • Neuraxpharm expands ADHD treatment options in Europe with Tuzulby and Paxneury launches
    Categories: Central Nervous System, Child & Adolescnt Health, Drug Development, Pharmaceuticals and therapeutics
  • FluoSphera raises €1.23 million to scale human-based preclinical testing platform
    Categories: Artificial Intelligence, Drug Development, European biotech, Partnerships & Funding, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top